Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

miR-195-5p reduces hair growth ability in cells by blocking a specific growth signal.

A group has developed therapies that show promise for treating cancer and various other conditions.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Adrenal disorders can cause lasting brain and behavior issues in children.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Bioengineered salivary glands in mice can produce saliva when tasting sour or bitter, but have different protein levels and nerve signals compared to natural glands.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.